Log In
Print
BCIQ
Print
Print this Print this
 

LY2523199

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
Description11beta-hydroxysteroid dehydrogenase type 1 (11b HSD1) inhibitor
Molecular Target Hydroxysteroid 11-beta dehydrogenase 1 (HSD11B1) (HSD1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today